Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.31 USD | -3.10% |
|
+1.53% | -8.92% |
Jun. 05 | Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing | MT |
May. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 462M | Sales 2025 * | 543M | Capitalization | 1.87B |
---|---|---|---|---|---|
Net income 2024 * | 117M | Net income 2025 * | 161M | EV / Sales 2024 * | 3.03 x |
Net cash position 2024 * | 469M | Net cash position 2025 * | 700M | EV / Sales 2025 * | 2.15 x |
P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
12.3
x | Employees | 167 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.79% |
Latest transcript on Catalyst Pharmaceuticals, Inc.
1 day | +0.19% | ||
1 week | +4.29% | ||
Current month | +2.00% | ||
1 month | -2.29% | ||
3 months | +3.54% | ||
6 months | -7.66% | ||
Current year | -6.01% |
![Extreme 14.96](/images/extremecours_fleche.png)
![Extreme 14.75](/images/extremecours_fleche.png)
![Extreme 13.1161](/images/extremecours_fleche.png)
![Extreme 11.55](/images/extremecours_fleche.png)
![Extreme 4.81](/images/extremecours_fleche.png)
![Extreme 2.55](/images/extremecours_fleche.png)
![Extreme 0.51](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Patrick McEnany
FOU | Founder | 76 | 01-12-31 |
Richard Daly
CEO | Chief Executive Officer | 62 | 15-02-18 |
Michael Kalb
DFI | Director of Finance/CFO | 53 | Dec. 31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick McEnany
FOU | Founder | 76 | 01-12-31 |
Donald Denkhaus
BRD | Director/Board Member | 78 | 15-02-18 |
David Tierney
BRD | Director/Board Member | 60 | 02-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.05% | 28 M€ | -4.37% | ||
0.32% | 26 M€ | -6.65% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-03 | 15.31 | -3.10% | 389 435 |
24-07-02 | 15.8 | +0.19% | 773,594 |
24-07-01 | 15.77 | +1.81% | 837,171 |
24-06-28 | 15.49 | +2.99% | 1,920,395 |
24-06-27 | 15.04 | -0.27% | 601,718 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.01% | 1.87B | |
+6.58% | 41.61B | |
-11.57% | 33.32B | |
+78.52% | 28.8B | |
-14.73% | 15.61B | |
-6.00% | 13.27B | |
-12.55% | 11.46B | |
+166.50% | 10.06B | |
-54.80% | 9.09B | |
+2.47% | 8.9B |
- Stock Market
- Equities
- CPRX Stock